Expand CLLS Menu
CLLS MENU

CLLS Latest Press Releases

-- July 15, 2026 --

Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio Globe Newswire 8:00 AM

-- June 25, 2026 --

Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026 Globe Newswire 4:30 PM

-- June 11, 2026 --

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress Globe Newswire 2:40 AM

-- June 9, 2026 --

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL Globe Newswire 4:30 PM

-- May 20, 2026 --

Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026 Globe Newswire 4:30 PM

-- May 12, 2026 --

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress Globe Newswire 9:30 AM

-- May 11, 2026 --

Cellectis Reports Financial Results for the First Quarter 2026 Globe Newswire 4:30 PM

-- May 4, 2026 --

Cellectis to Report First Quarter Financial Results on May 11, 2026 Globe Newswire 4:30 PM

-- April 27, 2026 --

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting Globe Newswire 4:30 PM

-- April 13, 2026 --

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis' Allogeneic CAR-T Platform Globe Newswire 4:30 PM

-- March 12, 2026 --

Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 Globe Newswire 4:30 PM
Market Data Delayed 15 Minutes